PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*mel, our first drug candidate is currently in phase 1 clinical trials for melanoma. PDC*lung is in preclinical development for lung cancer. Our approach can be applied to virtually any type of cancer and any patient population, and combined with differents cancer treatments.
|HQ||La Tronche, FR||Map|
|Employees (est.) (May 2020)||18||(+6%)|
PDC Line Pharma total Funding
PDC Line Pharma latest funding size
Time since last funding
|4 months ago|
PDC Line Pharma investors
|Sambrinvest, Korean Investment Partners, Shinhan-Cognitive Start-up Fund, UTC 2019 BIOVENTUREFUND, The Regional Investment Company of Wallonia, the Belgian Federal Holding and Investment Company, Noshaq Group|
When was PDC Line Pharma founded?
PDC Line Pharma was founded in 2014.
Who are PDC Line Pharma key executives?
PDC Line Pharma's key executives are Eric Halioua, Laurent Levy and Joel Plumas.
How many employees does PDC Line Pharma have?
PDC Line Pharma has 18 employees.
Who are PDC Line Pharma competitors?
Competitors of PDC Line Pharma include Harbour Antibodies, GrayBug and Rebiotix.
Where is PDC Line Pharma headquarters?
PDC Line Pharma headquarters is located at 29 Avenue Maquis du Grésivaudan, La Tronche.
Where are PDC Line Pharma offices?
PDC Line Pharma has offices in La Tronche and Liège.
How many offices does PDC Line Pharma have?
PDC Line Pharma has 2 offices.
Receive alerts for 300+ data fields across thousands of companies